Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients [Phase 2]
A Phase 2 extension protocol investigates dose comparisons of leucine-metformin combinations in adults with type 2 diabetes mellitus; study …
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Adding Liraglutide to High Dose Insulin: Breaking the Cycle [Phase 4]
Phase 4 trial evaluating adding liraglutide to high-dose insulin in patients with type 2 diabetes mellitus and obesity; results posted in 20…
-
FDA approval · 2017-12-13FDA Approved: JARDIANCE — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Jardiance (empagliflozin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc., resulting in …
-
FDA approval · 2017-12-13FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SYNJARDY (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharm…
-
FDA approval · 2017-12-13FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SYNJARDY XR (empagliflozin/metformin hydrochloride extended-release) from Boehringer Ingelhe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042) [Phase 2]
Phase 2 study of ertugliflozin in adults with type 2 diabetes and hypertension completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Pioglitazone on Pancreatic Steatosis and Bone Health [NA]
A completed clinical trial evaluated the effects of pioglitazone on pancreatic steatosis and bone health in individuals with obesity and Typ…
-
FDA approval · 2017-12-12FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for TRULICITY (dulaglutide) submitted by Eli Lilly and Company.
-
FDA approval · 2017-12-12FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for XULTOPHY 100/3.6, a fixed-ratio combination of insulin degludec and liraglutide, by Novo Nor…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018) [Phase 3]
A Phase 3 cardiovascular outcomes trial for omarigliptin (MK-3102) in type 2 diabetes mellitus was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Vitamin D Supplementation on Cardiovascular Risk Factors [NA]
A completed clinical trial conducted by Florida International University evaluated the effect of Vitamin D supplementation on cardiovascular…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: The Relationship of Hemoglobin A1c and Diabetic Wound Healing [Phase 4]
Phase 4 clinical trial investigating the relationship between hemoglobin A1c and healing of diabetic wounds was terminated; results were pos…
-
FDA approval · 2017-12-11FDA Approved: ADMELOG — Original Application (Sanofi-Aventis U.S. LLC)
FDA approves ADMELOG (insulin lispro) from Sanofi-Aventis U.S. LLC under a Biologics License Application.
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes [NA]
A pilot study evaluated the safety and efficacy of 5-ALA-SFC in Type 2 diabetes; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Dietary Analyses in the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-Up Study
This clinical trial update reports completed dietary analyses across the Nurses' Health Study, Nurses' Health Study II, and Health Professio…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing IDegLira (insulin degludec/liraglutide) versus basal-bolus therapy in adults with Type 2 diabetes; results were post…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects [Phase 1]
A Phase 1 bioequivalence study evaluating fixed-dose combination tablets of Saxagliptin/Dapagliflozin/Metformin XR versus the individual com…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Randomized Trial to Evaluate the Effectiveness of Nurse Case Management [NA]
A Johns Hopkins–sponsored randomized trial evaluated the effectiveness of nurse case management for patients with Type 2 diabetes and gestat…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) [Phase 2]
Phase 2 dose-ranging study in treatment-naive type 2 diabetes mellitus has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) [Phase 4]
A Phase 4 clinical trial evaluating myocardial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease has complet…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Effects Of Resistive Exercise or Proprioceptive Exercise Training Among Patients With Type 2 Diabetes Mellitus [NA]
This clinical trial update reports on a completed study comparing resistive exercise versus proprioceptive exercise training in patients wit…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass [NA]
Clinical trial assessing the effects of exenatide, sitagliptin, or glimepiride on functional beta-cell mass in pre-diabetes and type 2 diabe…
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Comprehensive Awareness and Control in Diabetes Patients in China Jiangxi: A Cross-Sectional Survey
A cross-sectional survey in Jiangxi, China, evaluating how well blood glucose, blood pressure, and lipid levels are controlled among patient…
-
FDA approval · 2017-12-05FDA Approved: OZEMPIC — Original Application (Novo Nordisk)
The FDA approves Ozempic (semaglutide) under NDA209637 for adults with Type 2 diabetes mellitus to improve glycemic control (original applic…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial update comparing FIAsp (fast-acting insulin aspart) to insulin aspart, both used with insulin glargine and metformi…